Literature DB >> 7534118

Definition of a new entity of malignant extragonadal germ cell tumors.

J van Echten1, B de Jong, R J Sinke, D O Weghuis, D T Sleijfer, J W Oosterhuis.   

Abstract

Two malignant extragonadal germ cell tumors are reported, histologically classified as immature teratomas, having pseudodiploid karyotypes with complex structural rearrangements but lacking isochromosome 12p or other rearrangements involving 12p. The absence of 12p material in structural rearrangements was confirmed by chromosome painting. In the two tumors the following common chromosomal breakpoints were found: 6p21, 6p22, 6q23, and 11q13. Exactly the same chromosomal regions, 6p22::6q23 and 6p21::11q13, were involved in fusions. The two tumors belong to a new entity of extragonadal immature teratomas of adults which may be located in the retroperitoneum and posterior mediastinum and are prone to blood borne metastasis.

Entities:  

Mesh:

Year:  1995        PMID: 7534118     DOI: 10.1002/gcc.2870120103

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Infected mature teratoma of lower posterior mediastinum.

Authors:  Y K Sarin; A Sinha; M Sengar
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 1.967

Review 2.  [Mediastinal germ cell tumors].

Authors:  F Bremmer; P Ströbel
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

Review 3.  Molecular biology of testicular germ cell tumors.

Authors:  E Vilar; E Calvo; J Tabernero
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

4.  A Rare Case Presentation of Retroperitoneal Teratoma in Adults.

Authors:  Akanksha Rajpoot; Rajendra Benakatti; S S Prasad
Journal:  Indian J Surg Oncol       Date:  2021-08-24

Review 5.  Human germ cell tumours from a developmental perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2019-08-14       Impact factor: 60.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.